To kill or be killed: Viral evasion of apoptosis

Nature Immunology

Volumn 3, Issue 11, 2002, Pages 1013-1018

  Benedict, Christ A ^a   Norris, Paula S ^a   Ware, Carl F ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOKINE; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTATION; APOPTOSIS; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME REGULATION; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HOST CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE SYSTEM; LIFE CYCLE; LIFESPAN; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; NONHUMAN; PARASITE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CYSTEINE ENDOPEPTIDASES; CYTOKINES; HUMANS; INTERFERONS; MICE; MODELS, BIOLOGICAL; MOLECULAR MIMICRY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VERTEBRATES; VIRAL PHYSIOLOGY; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0036852215     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1102-1013     Document Type: Review

References (80)

1. Green, D. R. Apoptotic pathways: paper wraps stone blunts scissors. Cell 102, 1-4 (2000).
2. Medzhitov, R. Toll-like receptors and innate immunity. Nature Rev. Immunol. 1, 135-145 (2001).
3. Karin M. & Lin. A. NF-κB at the crossroads of life and death. Nature Immunol. 3, 221-227 (2002).
4. Harvey, M. et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet. 5, 225-229 (1993).
5. Kannan, K. et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20, 2225-2234 (2001).
6. Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
7. Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694 (2001).
8. Oda, E. et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-1058 (2000).
9. Wu, G. S. et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genes. 17, 141-143 (1997).
10. Gross, A., McDonnell, J. M. & Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
11. Lane, D. P. & Crawford, L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263 (1979).
12. Linzer, D. I. & Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52 (1979).
13. Steegenga, W.T., Riteco, N., Jochemsen, A. G., Fallaux, F.J. & Bos, J. L. The large EIB protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16, 349-357 (1998).
14. Querido, E. et al. Degradation of p53 by adenovirus E4orf6 and EIB55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15, 3104-3117 (2001).
15. Scheffner, M., Werness, B.A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136 (1990).
16. Werness, B.A., Levine, A. J. & Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79 (1990).
17. Wang, X.W. et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55, 6012-6016 (1995).
18. White, E., Cipriani, R., Sabbatini, P. & Denton, A. Adenovirus EIB 19-kilodalton protein overcomes the cytotoxicity of EIA proteins. J. Virol. 65, 2968-2978 (1991).
19. White, E. Regulation of apoptosis by adenovirus EIA and EIB oncogenes. Semin. Virol. 8, 505-513 (1998).
20. Henry, H., Thomas, A., Shen, Y. & White, E. Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death. Oncogene 21, 748-760 (2002).
21. Sundararajan, R. & White, E. EIB 19K blocks Bax oligomerization and tumor necrosis factor α mediated apoptosis. J. Virol. 75, 7506-7516 (2001).
22. Henderson, S. et al. Epstein-Barr virus-coded BHRFI protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90, 8479-8483 (1993).
23. L are resistant to human immunodeficiency virus-I-induced apoptosis and human immunodeficiency virus-1 replication. Virology 256, 1-7 (1999).
24. Sarid, R., Sato, T., Bohenzky, R.A., Russo, J.J. & Chang, Y. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nature Med. 3, 293-298 (1997).
25. Cheng, E. H. et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94, 690-694 (1997).
26. Gangappa, S., van Dyk, L. F., Jewett, T. J., Speck, S. H. & Virgin, H.W. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195, 931-940 (2002).
27. Goldmacher V. S. et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96, 12536-12541 (1999).
28. L expression by human T-cell leukemia virus type I Tax through NF-κB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 73, 7981-7987 (1999).
29. Wolf, D. et al. HIV-1 Nef associated PAK and P13-kinases stimulate Akt-independent Bad- phosphorylation to induce anti-apoptotic signals. Nature Med. 7, 1217-1224 (2001).
30. Munger, J. & Roizman, B. The US3 protein kinase of herpes simplex virus I mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc. Natl. Acad. Sci. USA 98, 10410-10415 (2001).
31. Earnshaw, W. C., Martins, L. M. & Kaufmann, S. H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424 (1999).
32. Huang, H. et al. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275, 26661-26664 (2000).
33. Suzuki, Y., Nakabayashi, Y. & Takahashi, R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA 98, 8662-8667 (2001).
34. Deveraux, Q. L. & Reed, J. C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13, 239-252 (1999).
35. Hay, B. A. Understanding IAP function and regulation: a view from Drosophila. Cell Death Differ. 7, 1045-1056 (2000).
36. Clem, R. J. Baculoviruses and apoptosis: the good, the bad, and the ugly. Cell Death Differ. 8, 137-143 (2001).
37. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9, 459-470 (2002).
38. Neilan, J. G. et al. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRFI. J. Virol. 67, 4391-4394 (1993).
39. Miura, M., Friedlander, R. M. & Yuan, J. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA 92, 8318-8322 (1995).
40. Talley, A. K. et al. Tumor necrosis factor α-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366 (1995).
41. Tewari, M. & Dixit, V. M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260 (1995).
42. Wallach, D. et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367 (1999).
43. Smith, C. A. et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1024 (1990).
44. Reading, P. C., Khanna, A. & Smith, G. L. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292, 285-298 (2002).
45. Upton, C., Macen, J., Schreiber, M. & McFadden, G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370-382 (1991).
46. Schreiber, M., Sedger, L. & McFadden, G. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 71, 2171-2181 (1997).
47. Brojatsch, J., Naughton, J., Rolls, M. M., Zingler, K. & Young, J. A. CAR 1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87, 845-855 (1996).
48. Benedict, C. et al. Cutting edge: A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol. 126, 6967-6970 (1999).
49. Raftery, M. J. et al. Herpes simplex virus type I infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190, 1103-1104 (1999).
50. Raftery, M. J. et al. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 15, 997-1009 (2001).
51. Uchida, J. et al. Mimicry of CD40 signals by Epstein-Barr virus LMPI in B lymphocyte responses. Science 286, 300-303 (1999).
52. Shisler J., Yang, C., Walter, B., Ware, C. & Gooding, L. The adenovirus E3-10. 4K/14.5K complex mediates loss of cell surface fas (CD95) and resistance to fas-induced apoptosis. J. Virol. 71, 8299-8306 (1997).
53. Tollefson, A. E. et al. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392, 726-730 (1998).
54. Stewart A. R., Tollefson, A. E., Krajcsi, P., Yei, S. P. & Wold, W. S. The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane J. Virol. 69, 172-181 (1995).
55. Benedict, C. A. et al. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 276, 3270-3278 (2001).
56. Piguet, V., Schwartz, O., Le Gall, S. & Trono, D. The downregulation of CD4 and MHC-1 by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol. Rev. 168, 51-63 (1999).
57. Lama, J. & Ware, C. F. Human immunodeficiency virus type I Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells. J. Virol. 74, 9396-9402 (2000).
58. Overbaugh, J. & Bangham, C. R. M. Selection forces and constraints on retroviral sequence variation. Science 292, 1106-1109 (2001).
59. Ashkenazi, A. & Dixit, V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell. Biol. 11, 255-260 (1999).
60. Sedger, L. M. et al. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163, 920-926 (1999).
61. Vidalain, P. O. et al. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74, 556-559 (2000).
62. Kayagaki, N. et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163, 1906-1913 (1999).
63. Fanger, N. A., Maliszewski, C. R., Schooley, K. & Griffith, T. S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190, 1155-1164 (1999).
64. Bertin, J. et al. Death effector domain-containing herpesvius and poxvirus proteins inhibit both Fas- and TNFRI-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176 (1997).
65. Thome, M. & Tschopp, J. Regulation of lymphocyte proliferation and death by FLIP. Nature Rev. Immunol. 1, 50-58 (2001).
66. Krueger, A., Schmitz, I., Baumann, S., Krammer, P. H. & Kirchhoff, S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276, 20633-20640 (2001).
67. Skaletskaya, A. et al. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc. Natl. Acad. Sci. USA 7829-7834 (2001).
68. Chaudhary, P. M., Jasmin, A., Eby, M.T. & Hood, L. Modulation of the NF-κB pathway by virally encoded death effector domains-containing proteins. Oncogene 18, 5738-5746 (1999).
69. Guidotti, L. G. & Chisari, F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91 (2001).
70. Darnell, J. E. Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18, 549-554 (1998).
71. Tan, S. L. & Katze, M. G. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19, 543-554 (1999).
72. Castelli, J. C. et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186, 967-972 (1997).
73. Meurs, E. et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390 (1990).
74. Chu, W. M. et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11, 721-731 (1999).
75. Jagus, R., Joshi, B. & Barber, G. N. PKR, apoptosis and cancer. Int. J. Biochem. Cell. Biol. 31, 123-138 (1999).
76. Barber, G. N. Host defense, viruses and apoptosis. Cell Death Differ. 8, 113-126 (2001).
77. Browne, E. P., Wing, B., Coleman, D. & Shenk, T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAS. J. Virol. 75, 12319-12330 (2001).
78. Preston, C. M., Harman, A. N. & Nicholl, M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type I or human cytomegalovirus. J. Virol. 75, 8909-8916 (2001).
79. Benedict. C. A. et al. Lymphotoxins and cytomegalovirus cooperatively induce interferon-β, establishing host-virus détente. Immunity 15, 617-626 (2001).
80. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000).